AVGO Financial Statements & Analysis
Complete financial statements for AVGO including income statement, balance sheet, and cash flow statement. Analyze AVGO's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
23.9% ↑
Net Income
292.3% ↑
Gross Margin
7.5% ↑
Operating Margin
52.8% ↑
Balance Sheet
Current Ratio
45.3% ↑
Debt to Equity
-19.7% ↑
Asset Turnover
19.9% ↑
Cash Flow
Operating Cash Flow
37.9% ↑
Net Cash Flow
241.1% ↑
Free Cash Flow
38.6% ↑
Cash Flow to Debt
43.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 51.57B | 63.89B | 23.9% | |
| Gross Profit | 32.51B | 43.29B | 33.2% | |
| Operating Income | 13.46B | 25.48B | 89.3% | |
| Net Income | 5.89B | 23.13B | 292.3% | |
| EPS | 1.27 | 4.91 | 286.6% | |
| EBITDA | 23.88B | 34.71B | 45.4% | |
| Gross Margin | 63.03% | 67.77% | 7.5% | |
| Operating Margin | 26.10% | 39.89% | 52.8% | |
| Net Income Margin | 11.43% | 36.20% | 216.7% | |
| R&D Expenses | 9.31B | 10.98B | 17.9% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 63.89B | 51.57B | 35.82B | — | — |
| Gross Profit | 43.29B | 32.51B | 24.69B | — | — |
| Operating Income | 25.48B | 13.46B | 16.21B | — | — |
| Net Income | 23.13B | 5.89B | 14.08B | — | — |
| EPS | 4.91 | 1.27 | 3.39 | — | — |
| EBITDA | 34.71B | 23.88B | 20.55B | — | — |
| Gross Margin | 67.77% | 63.03% | 68.93% | — | — |
| Operating Margin | 39.89% | 26.10% | 45.25% | — | — |
| Net Income Margin | 36.20% | 11.43% | 39.31% | — | — |
| R&D Expenses | 10.98B | 9.31B | 5.25B | — | — |
Financial Metrics
Want to dive deeper into AVGO's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics